---
title: "Crestchem Ltd (526269) — Share Price, Financials & Analysis"
symbol: "526269"
company: "Crestchem Ltd"
canonical: "https://tapetide.com/stocks/526269"
isin: "INE293N01016"
nse_symbol: "CRESTCHEMLTD"
bse_code: "526269"
sector: "Chemicals"
industry: "Specialty Chemicals"
market_cap_cr: 40.91
generated_at: "2026-09-13T19:39:16.957Z"
---

# Crestchem Ltd (526269)

Canonical page: https://tapetide.com/stocks/526269

## Company

- **NSE Symbol:** CRESTCHEMLTD
- **BSE Code:** 526269
- **ISIN:** INE293N01016
- **Sector:** Chemicals
- **Industry:** Specialty Chemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** crestchemlimited.in

## About

Incorporated in 1991, Crestchem Ltd is in 
the field of processing, manufacturing, and trading and marketing, of specialty chemical
 ingredients,[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:37:56.333796Z.

- **Market Cap:** ₹40.91 Cr
- **Classification:** Microcap
- **P/E (reported):** 15.1
- **EPS (TTM):** ₹11.14
- **EPS (reported):** ₹8.36
- **Book Value:** ₹32.95
- **Price to Book:** 4.14
- **Dividend Yield:** 1.1%
- **ROE:** 27.38%
- **ROCE:** 37.82%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹30.3 Cr
- **Net Income:** ₹2.7 Cr
- **EBITDA:** ₹3.8 Cr
- **52-Week High:** ₹154.55
- **52-Week Low:** ₹73.01
- **RSI (14):** 59.95

## Tapetide Score

- **Score:** 66 / 100
- **Score date:** 2026-09-04
- **Archetype:** Quality at a Reasonable Price
- **What it means:** Financial strength is not being paid for with a demanding multiple. The question worth asking is whether the quality is durable or reflects a good patch — check the consistency of returns over several years rather than the latest quarter.
- **Pillar profile:** Quality: Good · Valuation: Fair · Momentum: Rising
- **Percentile:** 97.4 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 81.74 | 9% |
| growth | 79.69 | 9% |
| momentum | 91.21 | 12% |
| ownership | 48.06 | 24% |
| quality | 75.99 | 22% |
| valuation | 54.26 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company is expected to give good quarter
- Company has a good return on equity (ROE) track record: 3 Years ROE 40.6%

### Weaknesses

- Promoter holding is low: 29.8%
- Debtor days have increased from 36.2 to 44.8 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 109.88% | 734.88% | — |
| ebitda margin growth | -18.75% | — | — | — |
| net income growth | -18.18% | 35% | 58% | 37% |
| revenue growth | -8.65% | 36% | 21% | 31% |
| roce | -16.35% | — | — | — |
| roe | -14.55% | — | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 4.49 | 7.36 | 5.63 | 5.25 | 7.8 | 4.8 | 7.23 | 5.03 | 7.19 | 7.16 | 10.23 | 9.18 |
| Expenses | 4.08 | 6.13 | 4.78 | 4.49 | 6.53 | 4.15 | 6.63 | 4.67 | 6.58 | 6.35 | 8.83 | 8 |
| Operating Profit | 0.41 | 1.23 | 0.85 | 0.76 | 1.27 | 0.65 | 0.6 | 0.36 | 0.61 | 0.81 | 1.4 | 1.18 |
| OPM % | 9.13 | 16.71 | 15.1 | 14.48 | 16.28 | 13.54 | 8.3 | 7.16 | 8.48 | 11.31 | 13.69 | 12.85 |
| Other Income | 0.06 | 0.06 | 0.09 | 0.08 | 0.12 | 0.09 | 0.14 | 0.13 | 0.15 | 0.18 | 0.2 | 0.2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
| Profit before tax | 0.46 | 1.28 | 0.93 | 0.83 | 1.38 | 0.73 | 0.72 | 0.47 | 0.74 | 0.97 | 1.57 | 1.36 |
| Tax % | 26.09 | 28.91 | 27.96 | 27.71 | 28.26 | 27.4 | 15.28 | 25.53 | 25.68 | 25.77 | 30.57 | 27.94 |
| Net Profit | 0.34 | 0.91 | 0.66 | 0.6 | 1 | 0.52 | 0.61 | 0.35 | 0.54 | 0.72 | 1.1 | 0.98 |
| EPS in Rs | 1.13 | 3.03 | 2.2 | 2 | 3.33 | 1.73 | 2.03 | 1.17 | 1.8 | 2.4 | 3.67 | 3.27 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.05 | 0.1 | 6.15 | 7.62 | 7.9 | 16.66 | 21.18 | 24.98 | 29.42 | 33.76 |
| Expenses | 0.29 | 0.26 | 5.59 | 6.95 | 7.15 | 15.84 | 18.4 | 21.66 | 26.24 | 29.76 |
| Operating Profit | -0.24 | -0.16 | 0.56 | 0.67 | 0.75 | 0.82 | 2.78 | 3.32 | 3.18 | 4 |
| OPM % | -480 | -160 | 9.11 | 8.79 | 9.49 | 4.92 | 13.13 | 13.29 | 10.81 | 11.85 |
| Other Income | 0.03 | 0.02 | 0.03 | 0.05 | 0.08 | 0.15 | 0.26 | 0.44 | 0.66 | 0.73 |
| Interest | 0.01 | 0.01 | 0 | 0.02 | 0.02 | 0.01 | 0.01 | 0.05 | 0.01 | 0.02 |
| Depreciation | 0 | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.05 | 0.05 | 0.07 | 0.07 |
| Profit before tax | -0.22 | -0.16 | 0.57 | 0.68 | 0.78 | 0.94 | 2.98 | 3.66 | 3.76 | 4.64 |
| Tax % | -13.64 | 0 | 22.81 | 14.71 | 26.92 | 26.6 | 27.85 | 25.41 | 27.93 | — |
| Net Profit | -0.19 | -0.17 | 0.44 | 0.57 | 0.57 | 0.69 | 2.15 | 2.73 | 2.71 | 3.34 |
| EPS in Rs | -0.63 | -0.57 | 1.47 | 1.9 | 1.9 | 2.3 | 7.17 | 9.1 | 9.03 | 11.14 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 6.98 | 10.99 | 16.61 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves | -2.16 | -2.36 | -2.53 | -2.08 | -1.51 | -0.94 | -0.25 | 1.9 | 4.48 | 6.89 |
| Borrowings | 0.6 | 0.14 | 0.28 | 0.02 | 0.63 | 0.27 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.05 | 0.04 | 0.14 | 1.35 | 0.87 | 0.96 | 2.04 | 2.24 | 3.07 | 6.4 |
| Total Liabilities | 1.49 | 0.82 | 0.89 | 2.29 | 2.99 | 3.29 | 4.79 | 7.14 | 10.55 | 16.29 |
| Fixed Assets | 0.04 | 0.11 | 0.12 | 0.1 | 0.14 | 0.11 | 0.1 | 0.17 | 0.26 | 0.19 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 |
| Other Assets | 1.45 | 0.71 | 0.77 | 2.19 | 2.85 | 3.18 | 4.69 | 6.97 | 10.29 | 16.02 |
| Total Assets | 1.49 | 0.82 | 0.89 | 2.29 | 2.99 | 3.29 | 4.79 | 7.14 | 10.55 | 16.29 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.04 | -0.7 | -0.02 | 0.33 | 0.39 | 0.82 | 2.21 | 0.35 | 1.66 | 3.59 |
| Cash from Investing Activity | 0.64 | 0.12 | 0.01 | -0.35 | -0.39 | -0.83 | -1.34 | -1.07 | -0.99 | -3.75 |
| Cash from Financing Activity | -0.04 | -0.01 | -0.01 | 0 | -0.02 | -0.02 | -0.01 | -0.01 | -0.09 | -0.17 |
| Net Cash Flow | 0.55 | -0.58 | -0.02 | -0.02 | -0.01 | -0.02 | 0.86 | -0.72 | 0.59 | -0.33 |
| Free Cash Flow | -0.07 | -0.81 | -0.02 | 0.32 | 0.33 | 0.82 | 2.19 | 0.23 | 1.52 | 3.59 |
| CFO/OP | 20 | 292 | 12 | 75 | 75 | 139 | 300 | 43 | 56 | 129 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 469.29 | 730 | 292 | 71.81 | 67.54 | 41.58 | 0.44 | 26.37 | 37.41 | 44.79 |
| Inventory Days | 73 | 0 | 182.5 | 0.75 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Payable | 73 | — | 365 | 91.06 | — | — | — | — | — | — |
| Cash Conversion Cycle | 469.29 | 730 | 109.5 | -18.5 | 67.54 | 41.58 | 0.44 | 26.37 | 37.41 | 44.79 |
| Working Capital Days | -1016.79 | 438 | -292 | 3.56 | 12.93 | -2.77 | -36.81 | -1.21 | 8.47 | -14.02 |
| ROCE % | -8.6 | -18.92 | -19.61 | 67.46 | 45.75 | 35.96 | 37.4 | 78.17 | 59.94 | 43.41 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 31.92% | 32.09% | 32.11% | 32.05% | 32.04% | 32.11% | 32.22% | 29.43% | 29.69% | 29.94% | 30.04% | 29.76% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.13% | 0.13% | 0.13% | 0.13% | 0.13% | 0.13% | 0.13% | 0.13% | 0.13% | 0.13% | 0.13% | 0.13% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 66.09% | 65.86% | 65.81% | 65.71% | 65.53% | 65.62% | 65.38% | 66.63% | 66.28% | 65.99% | 65.91% | 66.02% |
| Others | 1.86% | 1.92% | 1.95% | 2.12% | 2.3% | 2.14% | 2.28% | 3.82% | 3.9% | 3.94% | 3.92% | 4.09% |
| No. of Shareholders | 11461 | 11510 | 11456 | 11931 | 12423 | 12966 | 12886 | 12843 | 12851 | 12682 | 12619 | 12500 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 4 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 133.26 | Buy |
| EMA (10) | 134.4 | Buy |
| SMA (20) | 129.89 | Buy |
| EMA (20) | 132.04 | Buy |
| SMA (50) | 129.83 | Buy |
| EMA (50) | 130.1 | Buy |
| SMA (100) | 129.45 | Buy |
| EMA (100) | 126.42 | Buy |
| SMA (200) | 114.44 | Buy |
| EMA (200) | 127.85 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 64.51 | Neutral |
| MACD (12,26,9) | 2.27 | Buy |
| Stochastic (14,3,3) | 82.42 | Sell |
| ADX (14) | 17.88 | Neutral |
| Williams %R (14) | -13.54 | Sell |
| ATR (14) | 7.37 | High Volatility |
| ROC (12) | 12.2 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 67.98 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fb3e411-7e5f-45d6-9c89-484ec9c23a59.pdf) |
| 2026-09-03 | [Board Meeting Intimation for Appointment Of Assistant Company Secretary Mr. Indrajyot Bagga Having ACS NO: 81745 Wef 08092026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c7df6a4-12ec-4d15-b588-5c63eebb7589.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14270f3a-783d-4380-9451-83f5264aef45.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Submission Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026 Regulation 30 & 33 And Part A Of Schedule Ill Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b283d1aa-4a9e-41b6-80ec-0450f5c10abb.pdf) |
| 2026-08-08 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa8d15dd-634a-4bc3-b9da-145a02cc6d2a.pdf) |
| 2026-08-07 | [Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday At 04:30 Pm (Noon) August 12 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ca89b00-0ef4-4ae3-ba14-c22fb21b2edf.pdf) |
| 2026-08-07 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66d889e9-b154-4592-99e3-e7da9015c730.pdf) |
| 2026-08-06 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=351dd4a9-94d5-473f-8ecc-c40aff68d15b.pdf) |
| 2026-08-04 | [Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) As Amended](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b562a54-09cc-48c7-bfe8-b1aad2147bae.pdf) |
| 2026-07-16 | [Corporate Action Book Closure From Friday July 312026 To Thursday August 062026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=312f9da9-7bc1-41a0-a51b-909e16293376.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 May - Subsidiary OLEO BIOSCIENCES commenced business; pilot plant setup planned in Bangalore, production expected FY26-27 and FY27-28. | [Update Regarding Formation Of Subsidiary Company Namely OLEO BIOSCIENCES PRIVATE LIMITED 7 May - Subsidiary OLEO BIOSCIENCES commenced business; pilot plant setup planned in Bangalore, production expected FY26-27 and FY27-28.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b55aa1d5-207f-4807-9d18-856f95cdc114.pdf) |
| 7 May - Board formed OLEO BIOSCIENSES subsidiary, subscribed Rs7.5 lakh, filed INC-20A, and approved pilot facility setup. | [Board Meeting Outcome for Board Meeting Dated 07/05/2026 To Take Note Of Formation Of New Subsidiary Company OLEO BIOSCIENSES PRIVATE LIMITED At Bangalore, Karnataka 7 May - Board formed OLEO BIOSCIENSES subsidiary, subscribed Rs7.5 lakh, filed INC-20A, and approved pilot facility setup.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/dc572d77-3805-4621-b257-6504bf987ed0.pdf) |
| 6 May - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 May - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/76bd8062-cdc8-4ada-bf85-eee5125c37f9.pdf) |
| 6 May - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 May - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/fdf2e5a4-3195-4941-93af-379f1a04581a.pdf) |
| 4 May - Crestchem says no material event exists, but has initiated steps for Oleo Biosciences Pvt Ltd subsidiary. | [Clarification On Price Movement 4 May - Crestchem says no material event exists, but has initiated steps for Oleo Biosciences Pvt Ltd subsidiary.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/06ed6d63-b97a-4c29-95fb-f94b5146193b.pdf) |
| 4 May - Crestchem says no material event exists, but has initiated steps for Oleo Biosciences Pvt Ltd subsidiary. | [Clarification On Price Movement 4 May - Crestchem says no material event exists, but has initiated steps for Oleo Biosciences Pvt Ltd subsidiary.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/06ed6d63-b97a-4c29-95fb-f94b5146193b.pdf) |
| 31 Mar - Reappointed Nirmit D. Patel as ED (01-04-2026 to 31-03-2031); remuneration subject to members' approval; hired Tansi Patel Rs30,000/month. | [Board Meeting Outcome for Out Of Board Meeting Dated 31-03-2026 31 Mar - Reappointed Nirmit D. Patel as ED (01-04-2026 to 31-03-2031); remuneration subject to members' approval; hired Tansi Patel Rs30,000/month.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8bc27779-5454-4876-b464-a8f701d573c3.pdf) |
| 3 Apr - Promoter group disclosed 9,01,049 shares, 30.03% holding, with no encumbrance as of 31 March 2026. | [Disclosure Under Regulation 30 (1) & 30 (2) Of SEBI ( SAST) Regulations,2011 3 Apr - Promoter group disclosed 9,01,049 shares, 30.03% holding, with no encumbrance as of 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/47ce8feb-2a91-4c2e-bd82-d9be24c00e61.pdf) |
| 26 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited Q4/year FY2026 results announcement. | [Closure of Trading Window 26 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited Q4/year FY2026 results announcement.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a301f21f-7d54-4c1d-bc63-02ba8b4f05c5.pdf) |
| 25 Mar - Board meeting March 31, 2026 to review 2025-26 performance, approve MD/ED remuneration, and issue duplicate share certificates. | [Board Meeting Intimation for General Discussion For The Performance During The Year 2025-26 & To Discuss The Plan For The Performance For The Coming Year 2026-27. Nitin S.Shah 25 Mar - Board meeting March 31, 2026 to review 2025-26 performance, approve MD/ED remuneration, and issue duplicate share certificates.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7c980873-23f4-4b11-9463-ba45aaead298.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c5a31d0d-f04d-4d31-98d9-dcb2746932ac.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0ef376f1-5298-49d7-b839-de2a04253b56.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4a3d0ad7-b0b1-4d5d-9471-1cd8f9819f29.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/872ee99d-fdb4-4d27-a135-91adeadbd771.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1a7435ae-b27c-4706-b1f1-9c6d9237556a.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8ec4f57e-4e69-4b8d-9a61-dad109b3239a.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/393f6d27-481c-407c-8a84-7c47f520a621.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/523329/75762523329.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/526269/73937526269.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/523329/70180523329.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8a6ac9ba-9e47-422c-9814-fe5885a028a7.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d11c5a1a-2946-4f55-8682-9fb5a8660ea5.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/439ec1ea-4321-4631-a7ec-04156de9c241.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6e327983-004a-4097-ae74-c86229f78fd5.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cc79ba0a-73f8-4aa3-bed1-c3a8af9ac4c4.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9b1e7e2e-c2ae-4dca-be95-00c2994475aa.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/647e49a8-7db4-4cdd-b0c1-77afca609fe7.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/177deb69-472d-4d21-a640-f7908b6415eb.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b66e0dce-a5eb-481a-ba2d-c7d873d77e54.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a3698c29-bb2d-47c8-91fb-99025e9faa61.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2024-11-12 | [Board Meeting Outcome for Limited Review Report Quarter 2 Unaudited](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d32c8004-1602-4b61-ab08-77d13fa155d3.pdf) |
| 2023-08-12 | [Board Meeting Outcome for Unaudited Result 30/06/2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17570d50-7b4b-432f-b05d-4660c71f5879.pdf) |
| 2023-05-15 | [Board Meeting Outcome for Regulation 33](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7ce165e-641b-4a78-b804-409ed853e03c.pdf) |
| 2023-02-11 | [Board Meeting Outcome for Outcome Of BM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0b2cbe8-4e86-4b15-8d5c-ad565429001b.pdf) |
| 2022-11-12 | [Financial Results Unaudited 30/09/22](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09163a5b-cc46-40a1-a8a2-dac34759fcf1.pdf) |
| 2022-08-08 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 08/08/2022 For Unaudited Financial Results For The Quarter Ended On 30Th June, 2022. REG. 30 (ANNOUCEMENT)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b0afd63-c356-406d-b532-2f5aa3bcc5d8.pdf) |
| 2022-05-30 | [Outcome Of Board Meeting Held On 30/05/2022 For Audited Financial Results For The Quarter Ended On 31 March, 2022 Together With The Audit Report.-REG. 30 (ANNOUCEMENT)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=371160fa-8754-440a-aa9f-f7acc6d2c9bf.pdf) |
| 2022-05-30 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 30/05/2022 For Audited Financial Results For The Quarter Ended On 31 March, 2022 Together With The Audit Report.-REG. 30 (ANNOUCEMENT)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a277e1e4-0d47-48ba-a18f-39984213266a.pdf) |
| 2022-02-08 | [Outcome Of Board Meeting Held On 08/02/2022 For Unaudited Financial Results For The Quarter Ended On 31St December, 2021. REG. 30 (ANNOUCEMENT)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=491502cf-28ab-4178-bfa1-069a28f5a041.pdf) |
| 2021-10-26 | [Financial Result 30/09/2021](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=295d841f-bed6-4237-9fe9-400925270936.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:39:16.957Z.